Navigation Links
The Lupus Foundation of America, Inc. Asks Supporters to Band Together for Lupus(SM)
Date:9/22/2009

The LFA asks people to join them and show their support by wearing a purple LFA wristband until there is an FDA-approved medication specifically for lupus

WASHINGTON, Sept. 22 /PRNewswire-USNewswire/ --It's been 50 years since the U.S. Food and Drug Administration (FDA) approved a medication to treat lupus -- when Dwight D. Eisenhower was President! To highlight the need for safer, more tolerable, and effective medications, the Lupus Foundation of America, Inc. (LFA) today launched its new campaign, Band Together for Lupus(SM), which encourages people to wear an LFA purple wristband until there is a medication approved specifically for lupus by the FDA. Current medications for lupus have unacceptable side effects that include bone loss and osteoporosis, infections, infertility, cancer, and more. The campaign also seeks to show support for those who are working to find new treatments and offer hope to the estimated 1.5 million Americans and 5 million people worldwide who have lupus.

"While we are encouraged that there are several promising treatments for lupus in the near-term pipeline there is still a lot of work to be done," said Sandra. C. Raymond, LFA President and CEO. "This is why we are asking all of our supporters to join us in 'banding together' for the millions of people who are affected by the disease."

The campaign Web site (www.lupus.org/bandtogether) allows people to purchase LFA wristbands, and complete a form pledging their support and commitment to wearing the wristband. The Web site also has more information on the campaign and how people can get involved and support the LFA.

About Lupus

Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two to three times more common among African Americans, Hispanics/Latinos, Native Americans, and Asians. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment or cure exists.

About the LFA

The Lupus Foundation of America, Inc. is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and its national network of chapters and support groups operate programs of research, education, and advocacy. To learn more, visit www.lupus.org.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lupus Worse in Blacks, Hispanics Than in Whites, Study Finds
2. The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs
3. Flu Shot May Be Less Effective in Those With Lupus
4. Immune responses to flu vaccine are diminished in lupus patients
5. LFAGW to Offer First Living with Lupus Baltimore Workshop on August 15
6. Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
7. LFAGW to Run Could I Have Lupus? Workshop on July 26; Mystics Game Follows
8. Basic Facts and Statistics About Lupus
9. The New York Times Website Patient Voices Series Features People Affected by Lupus
10. Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus
11. Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... to catalyze conversations in support of bold systems change models helping to achieve ... an event on September 21, 2017, “We the Future: Accelerating Sustainable Development Solutions” ...
(Date:8/17/2017)... ... August 17, 2017 , ... SeQuel Response announced today that for ... among the fastest-growing private companies in the U.S., putting it in the top 10 ... applied to the Inc. 5000 over the years, only a fraction have ...
(Date:8/17/2017)... ... 2017 , ... Dr. Charles W. Grimsley’s new book ... 9781498497626; $7.99, eBook, 9781498497633) focuses on the treatment of veterans diagnosed with posttraumatic ... through a progressive journey toward healing. This book will help readers learn to ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC recently ... is a member of the firm’s Commercial Litigation and Employment Law groups. , Ms. ... of knowledge in matters of employment litigation, commercial litigation and business disputes. Her experience ...
(Date:8/17/2017)... ... August 17, 2017 , ... A recent report indicates that circa 79 percent ... cited deficiencies in data integrity. The FDA outlines their expectations for quality critical instrumentation ... as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 4, 2017 The search for test results ... physician/patient consult has long been the goal of healthcare ... focus of the largest meeting of lab professionals and ... market research firm Kalorama Information.  The firm said scores ... or related supplies and software were at the American ...
Breaking Medicine Technology: